Crigler-Najjar type II in pregnancy: A case report
- PMID: 37720001
- PMCID: PMC10504887
- DOI: 10.1177/1753495X221099443
Crigler-Najjar type II in pregnancy: A case report
Abstract
Crigler-Najjar is a rare, autosomal recessive disorder that results in mutations causing a complete absence (type I) or deficiency (type II) of the hepatic uridine diphospho-glucuronosyl transferase (UDPGT) enzyme. Both forms, however, result in unconjugated hyperbilirubinaemia which can lead to kernicterus and potentially death. Phenobarbitone can be used as an enzyme inducer in Type II to facilitate a reduction in total serum bilirubin. We report two consecutive pregnancies in a 29-year-old woman with Crigler-Najjar Type II syndrome. Phenobarbitone therapy was commenced in the first pregnancy at 16 weeks' gestation and was associated with favorable biochemical and clinical outcomes. There were no reports of long-term neonatal neurological sequelae. Tertiary center, multidisciplinary care is recommended for optimal pregnancy outcomes.
Keywords: Bilirubin; Crigler-Najjar; jaundice; phenobarbitone.
© The Author(s) 2022.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
References
-
- Shakuntala PN, Poornima M, Padmalatha VV, et al. Successful pregnancy outcome in maternal Crigler Najjar syndrome type II. Online J Health Allied Sci 2012; 11.
-
- Holstein A, Bryan CS. Three consecutive pregnancies in a woman with Crigler-Najjar syndrome type II with good maternal and neonatal outcomes. Dig Liver Dis 2011; 43: 70. - PubMed
-
- Passuello V, Puhl AG, Wirth S, et al. Pregnancy outcome in maternal Crigler-Najjar syndrome type II: a case report and systematic review of the literature. Fetal Diagn Ther 2009; 26: 121–126. - PubMed
Publication types
LinkOut - more resources
Full Text Sources